Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NATR
NATR logo

NATR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nature's Sunshine Products Inc (NATR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
20.120
1 Day change
0.20%
52 Week Range
28.140
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Nature's Sunshine Products Inc (NATR) is not a strong buy at the moment for a beginner investor with a long-term horizon. The technical indicators show a mixed trend with bearish moving averages and neutral RSI. Insider selling has increased significantly, which raises concerns about internal confidence. While analysts have raised the price target and highlighted growth opportunities in Germany and Asia, the lack of recent positive news, no strong trading signals, and the absence of financial performance data make it prudent to hold off on buying this stock right now.

Technical Analysis

The MACD histogram is positive at 0.14 and expanding, indicating bullish momentum. However, the RSI is neutral at 38.36, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 19.601, and resistance is at 20.789. The stock is trading below its pivot level of 20.195, suggesting weakness.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
1

Positive Catalysts

  • Analysts have raised the price target to $37 from $33, citing better-than-expected Q1 results and growth plans in Germany and Asia. The company is also rolling out its Synergy brand to the U.S. market.

Neutral/Negative Catalysts

  • Insider selling has increased by 161.97% over the last month, indicating potential lack of confidence. No recent news or significant trading trends from hedge funds. The stock has a 40% chance to decline in the next month by 3.17%.

Financial Performance

No financial performance data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Canaccord maintains a Buy rating and has raised the price target to $37, citing growth opportunities and strong Q1 results.

Wall Street analysts forecast NATR stock price to rise
2 Analyst Rating
Wall Street analysts forecast NATR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 20.080
sliders
Low
22
Averages
22.5
High
23
Current: 20.080
sliders
Low
22
Averages
22.5
High
23
Canaccord
Buy
maintain
$33 -> $37
AI Analysis
2026-05-08
Reason
Canaccord
Price Target
$33 -> $37
AI Analysis
2026-05-08
maintain
Buy
Reason
Canaccord raised the firm's price target on Nature's Sunshine to $37 from $33 and keeps a Buy rating on the shares. The firm said they reported better than expected Q1 results. Management highlighted plans to enter Germany and expand into two new high-value Asian markets using the Synergy Asia sales system. Management also noted they are rolling out the Synergy brand to the U.S. market through affiliates that know the brand well in Asia.
DA Davidson
Buy
maintain
$23 -> $33
2026-03-12
Reason
DA Davidson
Price Target
$23 -> $33
2026-03-12
maintain
Buy
Reason
DA Davidson raised the firm's price target on Nature's Sunshine to $33 from $23 and keeps a Buy rating on the shares. The company's beat and raise trend continues with Q4 results comfortably above consensus forecasts, and the firm sees further upward revisions as results underscore the extent to which the company's portfolio is under-penetrated across key markets, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NATR
Unlock Now

People Also Watch